Drupal.behaviors.print = function(context) {window.print();window.close();}>
Launch of PacBio RS Drives Q2 Revenue, but Investors Raise Concerns Over Pace of Uptake
August 09, 2011
Launch of PacBio RS Drives Q2 Revenue, but Investors Raise Concerns Over Pace of Uptake
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
PacBio Grows Order Backlog in Q4; Sees Increased Interest in Microbial Sequencing
February 22, 2011 / In Sequence
USPTO Board Rules on PacBio, Life Tech Patent Interference Case
February 1, 2011 / In Sequence
PacBio Reveals Beta System Specs for RS; Says Commercial Release is on Track for First Half of 2011
December 7, 2010 / In Sequence
PacBio Demos Improved Chemistry with E. coli Outbreak Sequencing; Plans Q4 Upgrade for RS
July 12, 2011 / In Sequence
PacBio Ships First Two Commercial Systems; Order Backlog Grows to 44
May 3, 2011 / In Sequence